Cic edizioni internazionali
Clinical Dermatology

Retention rate of systemic drugs in patients with chronic plaque psoriasis

Original Article, 8 - 14
Tag this article
Abstract
Enhanced HTML Full text PDF
Introduction. The retention rate (RR) is the proportion of patients who maintain the same drug in a given time period, and it is a tool for evaluating the effectiveness and safety of treatments.
Objective. Estimate the RR of systemic drugs in reallife patients with chronic plaque psoriasis.
Methods. Retrospective evaluation of 392 adult patients with psoriasis who received a systemic drug, including methotrexate (n=158), cyclosporine (n=35), acitretin (n=24), infliximab (n=61), etanercept (n=76) and adalimumab (n=38). RR was evaluated using the
Kaplan-Meier survival data analysis in which the event was drug discontinuation due to inefficacy or intolerance with log-rank tests. Cox proportional-hazards regression model was also estimated.
Results. The RR at 24 and 30 months (but not at 12 months) for TNF-α blockers was higher than methotrexate, cyclosporine and acitretin (p<0.001). Main cause of drug discontinuation was intolerance. No differences in RR were detected among TNF-α
blockers. In multivariate analysis the predictors of early drug discontinuation were having received any conventional drugs versus any TNF-α blockers, higher body mass index (HR 1.91, 95% C.I. 1.68-2.1; p=0.008) and having previously been treated with
more than three systemic drugs (HR 1.37, 95% C.I. 1.10-1.79; p=0.032).
Conclusions. RR of TNF-α blockers was higher than conventional drugs. Discontinuation of conventional drugs was mostly due to intolerance. RR of systemic drugs was negatively influenced by obesity and by history of previous drug failure.

Vol. 7 (No. 2) 2019 April - June

  1. A case report of atypical presentation of pyoderma gangrenosum with ulcerative colitis: successful treatment with prednisolone and mesalazine therapy
    Abou-Taleb D. A.E, F. Sherif M., Mohammed A.S.
  2. Histopathological coexistence of extragenital lichen sclerosus and morphea in a single lesion: a case report
    Almuqati R., Hariri J., Abduljabbar M.
  3. Hedgehog pathway inhibitors for basal cell carcinoma: case reports and review of the literature
    Singer C., O’Sullivan N.-A., Vinciullo C.
  4. Sirolimus therapy for refractory kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: a case report
    Valsassina R., Contreiras M., Strecht J., Melo F., Oom P.
  5. Superimposed Mongolian spot and mucopolysaccharidosis VI
    Ribeiro E.M., Ribeiro Fontenele Bezerra K., César Cardoso-dos-Santos A., Lourenço C.M., Kiszewski A.E.
  6. First reported case of primary peritoneal malignancy with initial presentation as cutaneous metastases
    Wong V., Tharakaram S., Kontogiorgi D., Shahzad J., Burova E., Maidment G., Smith S., Vohra V.
Last Viewed articles: la lista degli ultimi x visitati.
  1. Retention rate of systemic drugs in patients with chronic plaque psoriasis
    Gisondi P., Tessari G., Di Mercurio M., Del Giglio M., Girolomoni G.
credits